|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 126.32 USD | -0.67% |
|
-2.28% | +0.48% |
| 12-17 | Morgan Stanley Adjusts Zoetis Price Target to $160 From $175, Maintains Overweight Rating | MT |
| 12-16 | Sector Update: Health Care Stocks Edge Higher Premarket Tuesday | MT |
Company Valuation: Zoetis Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 78,657 | 115,457 | 68,303 | 90,615 | 73,508 | 56,043 | 56,043 | - |
| Change | - | 46.79% | -40.84% | 32.67% | -18.88% | -23.76% | 0% | - |
| Enterprise Value (EV) 1 | 82,252 | 118,564 | 72,626 | 95,138 | 78,091 | 60,735 | 60,131 | 59,540 |
| Change | - | 44.15% | -38.75% | 31% | -17.92% | -22.23% | -1% | -0.98% |
| P/E ratio | 48.4x | 57.1x | 32.6x | 38.9x | 29.8x | 21.2x | 19.8x | 18.1x |
| PBR | 20.9x | 25.4x | 15.4x | 18.1x | 15.3x | 10.1x | 8.47x | 7.12x |
| PEG | - | 2.3x | 6.33x | 3x | 3.78x | 2.19x | 2.74x | 1.99x |
| Capitalization / Revenue | 11.8x | 14.8x | 8.45x | 10.6x | 7.94x | 5.94x | 5.65x | 5.35x |
| EV / Revenue | 12.3x | 15.2x | 8.99x | 11.1x | 8.44x | 6.43x | 6.06x | 5.69x |
| EV / EBITDA | 28x | 34.5x | 20.4x | 25.6x | 19.3x | 14.8x | 13.8x | 12.8x |
| EV / EBIT | 32.9x | 39.7x | 23.5x | 29.4x | 22.1x | 16.4x | 15.3x | 14.2x |
| EV / FCF | 49.2x | 68.3x | 54.8x | 58.7x | 34x | 25.3x | 21.8x | 19.8x |
| FCF Yield | 2.03% | 1.46% | 1.83% | 1.7% | 2.94% | 3.95% | 4.59% | 5.04% |
| Dividend per Share 2 | 0.85 | 1.075 | 1.35 | 1.557 | 1.796 | 1.983 | 2.235 | 2.413 |
| Rate of return | 0.51% | 0.44% | 0.92% | 0.79% | 1.1% | 1.56% | 1.76% | 1.9% |
| EPS 2 | 3.42 | 4.27 | 4.49 | 5.07 | 5.47 | 6 | 6.433 | 7.018 |
| Distribution rate | 24.9% | 25.2% | 30.1% | 30.7% | 32.8% | 33% | 34.7% | 34.4% |
| Net sales 1 | 6,675 | 7,776 | 8,080 | 8,544 | 9,256 | 9,441 | 9,916 | 10,471 |
| EBITDA 1 | 2,940 | 3,434 | 3,561 | 3,722 | 4,036 | 4,103 | 4,353 | 4,657 |
| EBIT 1 | 2,499 | 2,986 | 3,096 | 3,231 | 3,539 | 3,698 | 3,922 | 4,197 |
| Net income 1 | 1,638 | 2,037 | 2,114 | 2,344 | 2,486 | 2,684 | 2,816 | 3,044 |
| Net Debt 1 | 3,595 | 3,107 | 4,323 | 4,523 | 4,583 | 4,692 | 4,088 | 3,497 |
| Reference price 2 | 165.50 | 244.03 | 146.55 | 197.37 | 162.93 | 127.17 | 127.17 | 127.17 |
| Nbr of stocks (in thousands) | 475,268 | 473,126 | 466,072 | 459,114 | 451,165 | 440,693 | 440,693 | - |
| Announcement Date | 2/16/21 A | 2/15/22 A | 2/14/23 A | 2/13/24 A | 2/13/25 A | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.19x | 6.43x | 14.8x | 1.56% | 56.04B | |
| -4110.33x | 3.24x | 16.98x | -.--% | 11.66B | |
| 18.33x | 1.68x | 8.02x | 2.51% | 4.02B | |
| 19.61x | 2.14x | 10.66x | 0.43% | 3.55B | |
| 96.67x | - | - | 0.29% | 2.73B | |
| 49.35x | 4.22x | 15.09x | -.--% | 1.87B | |
| 19.77x | 1.46x | 9.09x | 1.22% | 1.6B | |
| 19.96x | 2.65x | 11.42x | 2.41% | 1.3B | |
| 17.81x | 1.52x | 7.74x | 1.02% | 1.19B | |
| 33.75x | - | - | 0.99% | 1.19B | |
| Average | -381.39x | 2.92x | 11.72x | 1.04% | 8.51B | |
| Weighted average by Cap. | -541.79x | 5.27x | 14.33x | 1.26% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- ZTS Stock
- Valuation Zoetis Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition